Distinct patterns of p27/KIP 1 gene expression in hepatoblastoma and prognostic implications with correlation before and after chemotherapy

Human Pathology

Volumn 33, Issue 2, 2002, Pages 198-205

  Brotto, Maurizio ^a   Finegold, Milton J ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Chemotherapy; Hepatoblastoma; p27

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P27;

ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CLONE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; MITOSIS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0036220817     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.31294     Document Type: Article

References (33)

1. Deregulation of the cell cycle in cancer
2. Cyclins and cell cycle checkpoints
3. The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases
4. p57Kip2, a structurally distinct member of the p1Cip1 Cdk inhibitor family, is a candidate tumor suppressor gene
5. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
6. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase activation
7. p27Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
8. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
9. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors
10. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1
11. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1-deficient mice
12. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kipl in human malignancies
13. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
14. p27 expression and gastric carcinoma
15. Downregulation of p27 is associated with development of colorectal adenocarcinoma metastases
16. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
17. Prognostic role of p27Kip1 and apoptosis in human breast cancer
18. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma
19. Loss of cell cycle regulators p27Kip1 and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival
20. p27Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
21. Pediatric liver tumors
22. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group
23. Randomized comparision of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma
24. Primary hepatic tumors of childhood
25. Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation
26. Hepatoblastoma. Attempt at characterization of histologic subtypes
27. Liver tumors
28. Small cell undifferentiated histology in hepatoblastoma is unfavorable histology
29. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology
30. Pathology of hepatoblastoma before and after chemotherapy (CHT). A morphological and immunohistochemical study of patients treated in the German liver tumor study
31. The prognostic implication of hypercholesterolemia in infants and children with hepatoblastoma
32. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
33. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma-A report from the German Cooperative Pediatric Liver Tumor Study